Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Surgery|December 8, 2007
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinomaEric Mirallié, Thomas Guillan, Boumédiene Bridji, et al.
Surgery|November 19, 2016
Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective studyGuénolé Simon, François Pattou, Eric Mirallié, et al.
Annals of Surgical Oncology|September 19, 2013
Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approachGianluca Donatini, Robert Caiazzo, Christine Do Cao, et al.
Annales D'Endocrinologie|July 6, 2016
Hyperparathyroidism complicating CYP 24A1 mutationsCamille Loyer, Clara Leroy, Arnaud Molin, et al.
European Journal of Medical Genetics|January 17, 2017
Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controlsBenjamin Kern, Lucie Coppin, Pauline Romanet, et al.
World Journal of Surgery|August 7, 2019
One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort StudyNiki Christou, Muriel Mathonnet, Sébastien Gaujoux, et al.
Surgery|December 12, 2003
When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?Patricia Niccoli-Sire, Arnaud Murat, Vincent Rohmer, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2018
Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvementSébastien Aubert, Amandine Berdelou, Viviane Gnemmi, et al.
Surgery|December 5, 2009
Local-regional recurrence of sporadic or syndromic abdominal extra-adrenal paraganglioma: incidence, characteristics, and outcomeSam Van Slycke, Robert Caiazzo, Pascal Pigny, et al.
Thyroid : Official Journal of the American Thyroid Association|July 12, 2014
MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapseFlorence Renaud, Viviane Gnemmi, Patrick Devos, et al.
Pageof 5